SNSS Financial Facts

Loss from operations: -11.6M
Other income (expense), net: 293K
See Full Income Statement

Total stockholders' equity: 15.84M
Accrued compensation: 1.29M
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date 11/12/14 *Est. EPS Growth Rate -11.1% *Last Qtr.
Average EPS % Beat Rate -6.4% Revenue Growth Rate +0.5% *Last Qtr.
Average % Move 1-Wk after EPS +1.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/14 Q214 -$0.20-$0.17 -$0.03$2M$1.32M N/A Details
5/7/14 Q114 -$0.26-$0.17 -$0.09$2M$1.32M N/A Details
3/6/14 Q413 -$0.15-$0.20 +$0.05$2M$1.37M N/A Details
11/12/13 Q313 -$0.16-$0.20 +$0.04$1.99M$1.44M N/A Details
7/29/13 Q213 -$0.18-$0.21 +$0.03$1.99M$1.22M N/A Details
5/9/13 Q113 -$0.23-$0.20 -$0.03$1.99M$750K N/A Details
3/13/13 Q412 -$0.20-$0.19 -$0.01$1.99M$320K N/A Details
11/8/12 Q312 -$0.37-$0.13 -$0.24$265K$4.17M N/A Details